IBBQ posted the stronger return over the past year, but has also experienced much higher historical volatility than XLV.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Amazon (AMZN) stock closed the July 31 trading session up 15.32% at $271.58, as it soared following the release of its second quarter (Q2) 2026 earnings report on July 30. The stock is up 17.66% year-to-date as of Saturday morning, August 1. Meanwhile, the SPDR S&P 500 index (SPY) is up about ...
NextEra Energy is about to become the second-largest nuclear energy company in the United States.
Russell 1000 fund delivered $1,735 on $1,000 invested over five years, while small-cap alternative returned $1,228 despite lower expense ratio.
PBE surged 41% in one year but endured a 35% drawdown, while XLV's diversified approach delivered steadier gains with half the volatility.
FHLC holds 334 positions versus IYH's 100, yet both delivered similar five-year returns despite their structural differences.
This ETF's focus on dividend stocks has paid off for investors over the years.
Warner Music Group currently trades at $29.22 per share and has shown little upside over the past six months, posting a small loss of 2.6%. The stock also fell short of the S&P 500’s 7.1% gain during that period.
Global investor positioning continues to reflect a generally positive outlook, although underlying strength is becoming increasingly concentrated in a smaller number of markets and sectors, according to Citi strategists. The bank said recent market activity suggests investors remain constructive overall, but divergences across regions and asset classes indicate that risks are beginning to build beneath the surface.
Over the past six months, PepsiCo’s shares (currently trading at $144.08) have posted a disappointing 6.2% loss, well below the S&P 500’s 7.1% gain. This may have investors wondering how to approach the situation.
Fastenal has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 10.9% to $48.10 per share while the index has gained 7.1%.
Investing.com -- Commodity trading advisers have largely unwound their Nasdaq-100 exposure, with the index’s short-term trend strength falling to just 13% against 53% for the S&P 500, BofA Securities said in a recent note.
Hartford trades at $145.37 and has moved in lockstep with the market. Its shares have returned 7.6% over the last six months while the S&P 500 has gained 7.1%.
HA Sustainable Infrastructure Capital trades at $37.80 and has moved in lockstep with the market. Its shares have returned 9.8% over the last six months while the S&P 500 has gained 7.1%.
In bull and bear markets, or robust and adverse economic backdrops, this business maintains its commitment to shareholders.
Investors looking for reliable income should examine these boring high-yield stocks to lock in attractive yields in a low-yield market.
Fed Chair Kevin Warsh and the Federal Open Market Committee (FOMC) are contending with elevated inflation, thanks in part to the president's policies.
Since January 2026, Figs has been in a holding pattern, posting a small loss of 0.5% while floating around $10.75. The stock also fell short of the S&P 500’s 7.1% gain during that period.
Bristol Myers Squibb's P/E ratio is below the industry average, but you have to take this key fact into consideration before buying it.
What triggered the latest focus on Ralph Lauren stock Ralph Lauren (RL) is back in focus after its stock outpaced the S&P 500 with a 2.72% gain on a recent trading day, ahead of an earnings release scheduled for August 6, 2026. This price move comes as the company prepares to report quarterly results that are expected to show higher earnings and revenue compared with the prior year, while analyst consensus on earnings has seen slight downward revisions. See our latest analysis for Ralph...
CRISPR Therapeutics Stock Reaction To Recent Trading Session CRISPR Therapeutics (NasdaqGM:CRSP) recently finished a trading session with a positive price move that outpaced the S&P 500. The stock is drawing attention as investors look ahead to its upcoming earnings report. See our latest analysis for CRISPR Therapeutics. At a share price of US$47.99, CRISPR Therapeutics has seen short term momentum cool, with a 30 day share price return down 13.72% and a 1 year total shareholder return down...
The space stock's three-year return laps the market many times over. What the pullback changed deserves just as much attention.
Ares Capital pays a lot of passive income.
The legendary investor has beaten the market by a wide margin, but he doesn't think you need to.
The S&P 500 has frequently dropped into correction territory during August in midterm election years.
Over the past six months, NVR’s shares (currently trading at $6,296) have posted a disappointing 18.4% loss, well below the S&P 500’s 4.9% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
The prevailing market dynamics serve as a strong tailwind for this tech stock.
W. R. Berkley trades at $73.39 and has moved in lockstep with the market. Its shares have returned 8.3% over the last six months while the S&P 500 has gained 4.9%.